Cangrelor During Percutaneous Coronary Intervention in Patients With Cardiogenic Shock or Cardiac Arrest
Open Access
- 14 April 2025
- journal article
- research article
- Published by Elsevier in JACC: Cardiovascular Interventions
- Vol. 18 (7) , 853-862
Abstract
No abstract availableKeywords
Funding Information
- Skanes universitetssjukhus Lund
This publication has 17 references indexed in Scilit:
- 2023 ESC Guidelines for the management of acute coronary syndromesEuropean Heart Journal, 2023
- Platelet Inhibition With Cangrelor and Crushed Ticagrelor in Patients With ST-Segment–Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary InterventionCirculation, 2019
- Cangrelor in cardiogenic shock and after cardiopulmonary resuscitation: A global, multicenter, matched pair analysis with oral P2Y12 inhibition from the IABP-SHOCK II trialResuscitation, 2019
- Clinical use of cangrelor: nationwide experience from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR)European Heart Journal - Cardiovascular Pharmacotherapy, 2019
- Effect of Platelet Inhibition with Cangrelor during PCI on Ischemic EventsNew England Journal of Medicine, 2013
- Optimal caliper widths for propensity‐score matching when estimating differences in means and differences in proportions in observational studiesPharmaceutical Statistics, 2011
- Intravenous Platelet Blockade with Cangrelor during PCINew England Journal of Medicine, 2009
- Platelet Inhibition with Cangrelor in Patients Undergoing PCINew England Journal of Medicine, 2009
- A Modified Poisson Regression Approach to Prospective Studies with Binary DataAmerican Journal of Epidemiology, 2004
- A Test of Missing Completely at Random for Multivariate Data with Missing ValuesJournal of the American Statistical Association, 1988